Gastric Insufflation and Laryngeal Mask Airway
Not Applicable
- Conditions
- Gastric Insufflation
- Registration Number
- NCT02097771
- Lead Sponsor
- Lionel Bouvet
- Brief Summary
Comparison of the incidence of gastric insufflation between two kinds of laryngeal masks airways: LMA SupremeTM vs Ambu AuraOnceTM
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- ASA 1 or 2
- Age > 18 yrs
- Use of laryngeal mask airway required
Exclusion Criteria
- risk of pulmonary aspiration of gastric contents
- Contraindication for the use of laryngeal mask airway
- Tracheal intubation required
- Patient's refusal
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method incidence of gastric insufflation during pulmonary ventilation through the laryngeal mask airway
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms behind gastric insufflation during laryngeal mask airway use?
How does the LMA SupremeTM compare to the AuraOnceTM in preventing gastric insufflation in clinical practice?
Are there specific biomarkers that correlate with reduced gastric insufflation risk when using laryngeal mask airways?
What adverse events are associated with gastric insufflation from laryngeal mask airways and how are they managed?
What alternative airway devices or techniques are being studied for gastric insufflation prevention compared to LMA SupremeTM and AuraOnceTM?
Trial Locations
- Locations (1)
Hospices Civils de Lyon
🇫🇷Lyon, France
Hospices Civils de Lyon🇫🇷Lyon, FranceBouvetContact+ 33 4 72 11 69 88